Collectively, these results suggest that the TMUB1–PD-L1 axis is involved in breast cancer and gastric cancer tumorigenesis, highlighting the potential of utilizing this axis as a therapeutic target in the treatment of breast and gastric cancers. Here, CD274 is linked to breast carcinoma.